Clinical Trial Update: Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating temozolomide, cisplatin, and nivolumab in colorectal cancer (colorectal adenocarcinoma) and currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Temozolomide (Temozolomide)
• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING